Recently, two studies have identified two individual MEF2C mutations in patients with SHF-related congenital heart disease (CHD) (Lu et al., 2018; Qiao et al., 2017), highlighting the importance of correct levels and function of MEF2C in human heart. This evidence concerns the gene SHF and coronary artery disorder.